Literature DB >> 30697628

Association between PPARs Gene Functional Polymorphisms and Ischemic Stroke in Chinese Uyghur Population.

Y Tong1, L Cai, Z Wang, Y Zhang, X Guan, F Zhan, J Liu, Q Lu.   

Abstract

PPARγ and PPARα belong to a receptor family of ligand-activated transcription factors involved in the regulation of inflammation, cellular glucose uptake, protection against atherosclerosis and endothelial cell function. Through these effects, they might be involved with the ischemic stroke (IS). We recruited 100 IS patients diagnosed by CTs or/and magnetic resonance imaging (MRI) and 100 normal healthy controls from Chinese Uyghur Population to assess the nature of the functional polymorphisms of PPARs and any links with IS in this unique population which has 60% European ancestry and 40% East Asian ancestry. We found that the Ala allele of the PPARγ Pro12Ala polymorphism was more common in controls than IS subjects (P = 0.008, corrected for multiple testing) in the Uyghur Population. Pro/Ala carriage may be associated with a decreased risk of IS in Uyghurs (OR 0.542, 95% CI 0.346-0.850). Additionally, the 162Val allele frequency at the DNA-binding region of PPARα was extremely rare in Chinese Uguhur IS patients and controls. Our population and ethnic-based study demonstrates that the 162Val allele frequency was extremely low in the Chinese Uyghur Population different from Some European and African populations and the PPARγ 12 Pro/Ala resulting in an amino acid exchange in N-terminal sequence may be an independent protective factor for IS in the Chinese Uyghur Population.

Entities:  

Keywords:  Ischemic stroke; Uyghur Population; functional polymorphisms; peroxisome proliferator-activated receptors (PPAR)-s

Mesh:

Substances:

Year:  2019        PMID: 30697628     DOI: 10.1007/s12603-018-1140-3

Source DB:  PubMed          Journal:  J Nutr Health Aging        ISSN: 1279-7707            Impact factor:   4.075


  48 in total

1.  Banting lecture 2001: dysregulation of fatty acid metabolism in the etiology of type 2 diabetes.

Authors:  J Denis McGarry
Journal:  Diabetes       Date:  2002-01       Impact factor: 9.461

2.  Inhibitory effect of a proline-to-alanine substitution at codon 12 of peroxisome proliferator-activated receptor-gamma 2 on thiazolidinedione-induced adipogenesis.

Authors:  J Masugi; Y Tamori; H Mori; T Koike; M Kasuga
Journal:  Biochem Biophys Res Commun       Date:  2000-02-05       Impact factor: 3.575

3.  Variation in the PPARalpha gene is associated with altered function in vitro and plasma lipid concentrations in Type II diabetic subjects.

Authors:  D M Flavell; I Pineda Torra; Y Jamshidi; D Evans; J R Diamond; R S Elkeles; S R Bujac; G Miller; P J Talmud; B Staels; S E Humphries
Journal:  Diabetologia       Date:  2000-05       Impact factor: 10.122

4.  A polymorphism, L162V, in the peroxisome proliferator-activated receptor alpha (PPARalpha) gene is associated with lower body mass index in patients with non-insulin-dependent diabetes mellitus.

Authors:  D Evans; J Aberle; D Wendt; A Wolf; U Beisiegel; W A Mann
Journal:  J Mol Med (Berl)       Date:  2001-05       Impact factor: 4.599

5.  Mutation screening of the PPARalpha gene in type 2 diabetes associated with coronary heart disease.

Authors:  C Lacquemant; F Lepretre; I Pineda Torra; M Manraj; G Charpentier; J Ruiz; B Staels; P Froguel
Journal:  Diabetes Metab       Date:  2000-11       Impact factor: 6.041

6.  Genetic determinants of the response to bezafibrate treatment in the lower extremity arterial disease event reduction (LEADER) trial.

Authors:  Y Jamshidi; D M Flavell; E Hawe; P K MacCallum; T W Meade; S E Humphries
Journal:  Atherosclerosis       Date:  2002-07       Impact factor: 5.162

7.  The human peroxisome proliferator-activated receptor alpha gene: identification and functional characterization of two natural allelic variants.

Authors:  A Sapone; J M Peters; S Sakai; S Tomita; S S Papiha; R Dai; F K Friedman; F J Gonzalez
Journal:  Pharmacogenetics       Date:  2000-06

8.  Comment: studies of the Pro12Ala polymorphism of the PPAR-gamma gene in the Danish MONICA cohort: homozygosity of the Ala allele confers a decreased risk of the insulin resistance syndrome.

Authors:  Laura Frederiksen; Kasper Brødbaek; Mogens Fenger; Torben Jørgensen; Knut Borch-Johnsen; Sten Madsbad; Søren A Urhammer
Journal:  J Clin Endocrinol Metab       Date:  2002-08       Impact factor: 5.958

9.  Peroxisome proliferator-activated receptor-gamma2 polymorphism Pro12Ala is associated with nephropathy in type 2 diabetes: The Berlin Diabetes Mellitus (BeDiaM) Study.

Authors:  Stefan-Martin Herrmann; Jens Ringel; Ji-Guang Wang; Jan A Staessen; Eva Brand
Journal:  Diabetes       Date:  2002-08       Impact factor: 9.461

Review 10.  The peroxisome proliferator-activated receptor-gamma2 Pro12Ala polymorphism.

Authors:  Michael Stumvoll; Hans Häring
Journal:  Diabetes       Date:  2002-08       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.